All stock lists
Unlock the score
Humacyte, Inc. (NASDAQ:HUMA)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.41-0.03 (-6.94%)
Insider Score
/ 100
HUMA Insider Score
Humacyte, Inc. has a live Insider Score.
Scored on 3 qualifying trades from 1 insider in the last 90 days.
HUMA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 406.00 K | 495.00 K | 467.00 K | 753.00 K | 301.00 K | 517.00 K |
| Revenue Growth (YoY) | 34.88 % | -4.26 % | -93.54 % | — | — | — |
| Cost of Revenue | 1.23 M | 2.04 M | 10.87 M | 2.13 M | 2.07 M | 1.98 M |
| Gross Profit | -825.00 K | -1.54 M | -10.40 M | -1.37 M | -1.77 M | -1.46 M |
| SG&A Expense | 8.03 M | 7.93 M | 5.83 M | 5.75 M | 7.81 M | 8.14 M |
| R&D Expense | 18.14 M | 19.46 M | 14.61 M | 17.27 M | 22.01 M | 15.42 M |
| Operating Expenses | 26.17 M | 27.39 M | 20.43 M | 23.02 M | 27.95 M | 21.72 M |
| Operating Income | -27.00 M | -28.93 M | -30.84 M | -24.39 M | -29.73 M | -23.18 M |
| Pretax Income | -36.80 M | -17.62 M | -24.80 M | -17.51 M | -37.66 M | 39.14 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -36.80 M | -17.62 M | -24.80 M | -17.51 M | -37.66 M | 39.14 M |
| EPS (Basic) | -0.16 | -0.09 | -0.15 | -0.11 | -0.24 | 0.28 |
| EPS (Diluted) | -0.16 | -0.09 | -0.15 | -0.11 | -0.24 | 0.28 |
| Shares Outstanding | 234.18 M | 197.85 M | 158.16 M | 158.31 M | 155.44 M | 131.50 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.